Stockreport

Regeneron (NASDAQ:REGN) Posts Better-Than-Expected Sales In Q4 CY2025 [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF Its non-GAAP profit of $11.44 per share was 6.9% above analysts' consensus estimates. Is now the time to buy Regeneron? Find out in our full research report Revenue: [Read more]